Biotech, biochemical, and pharmaceutical industry
Subsectors:
Description
We are the first and only biotechnology company in Lithuania manufacturing advanced therapy medicinal products (ATMPs) individually for each patient. We develop our products using patients’ own tissues and cells in the manufacturing process, and by addressing the specific needs of each person in field of: oncoimmunology, traumatology, auto-immune diseases and cosmetology. In addition to that we provide tissue bank services and contract manufacturing solutions.
Current export markets:
Export turnover: 20%
manufacturing advanced therapy medicinal products (ATMPs),
contracting manufacturing for clinical trials and ATMP R&D projects
SVF (stromal vascular fraction) cell product Dendritic cell vaccine T-cell product CIK (Cytokine-induced killer cells)
Certificates
GMP sertificate (iATMP),- Permission to produce dendritic cell activated with oncolysate (DLP)
Licenses
License for Tissue banking (stromal vascular fraction)- License for dendritic cell activated with oncolysate (DLP)
- License for the Cytokine Induced Killer cell preparation (CIK)
- License for the T – Cell Vacination (TCV)
- License for the Proprietary Stromal Vascular Fraction (SVFP)
Standards
ISO 9001- ISO 13845
- GMP (Good Manufacturing Practice)